Yi Zhun Zhu Selected Research

Yi Zhun Zhu Research Topics

Disease

12	Inflammation (Inflammations) 12/2021 - 07/2005
12	Infarction (Infarctions) 08/2020 - 08/2003
12	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 01/2007
10	Myocardial Infarction 08/2020 - 08/2003
6	Rheumatoid Arthritis 01/2022 - 12/2016
6	Ischemia 12/2021 - 07/2006
6	Hypoxia (Hypoxemia) 01/2011 - 01/2007
5	Stroke (Strokes) 12/2021 - 09/2009
5	Heart Failure 01/2019 - 04/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 07/2012
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2021 - 09/2009
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2018 - 01/2010
3	Anemia 10/2017 - 01/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 09/2006
3	Body Weight (Weight, Body) 04/2012 - 08/2003
3	Ischemic Stroke 11/2010 - 09/2006
2	Brain Ischemia (Cerebral Ischemia) 12/2021 - 01/2010
2	Neointima 01/2021 - 12/2018
2	Arthritis (Polyarthritis) 01/2021 - 01/2019
2	Pneumonia (Pneumonitis) 12/2020 - 07/2005
2	Atherosclerosis 01/2019 - 01/2018
2	Fibrosis (Cirrhosis) 01/2019 - 01/2017
2	Hyperplasia 12/2018 - 01/2018
2	Neoplasms (Cancer) 01/2011 - 06/2005
2	Alzheimer Disease (Alzheimer's Disease) 01/2011 - 09/2006
1	Non-alcoholic Fatty Liver Disease 06/2022
1	Metabolic Diseases (Metabolic Disease) 06/2022
1	Obesity 06/2022
1	Abdominal Obesity 06/2022
1	Insulin Resistance 01/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Hyperglycemia 01/2022
1	Overweight 08/2021
1	Osteoarthritis 08/2021
1	COVID-19 12/2020
1	Hypertension (High Blood Pressure) 12/2020
1	Cytokine Release Syndrome 01/2020
1	Colitis 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019

Drug/Important Bio-Agent (IBA)

18	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2021 - 07/2005
12	Cysteine (L-Cysteine)FDA Link 01/2021 - 08/2009
12	leonurineIBA 08/2020 - 06/2009
9	EnzymesIBA 01/2019 - 08/2003
7	Pharmaceutical PreparationsIBA 06/2022 - 07/2005
7	AntioxidantsIBA 01/2019 - 08/2003
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2007
5	sodium bisulfide (NaHS)IBA 10/2018 - 07/2005
4	LyasesIBA 01/2019 - 01/2011
4	Neuroprotective AgentsIBA 01/2018 - 09/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 08/2003
4	Therapeutic UsesIBA 05/2012 - 09/2009
3	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 12/2021
3	Histone DemethylasesIBA 01/2019 - 01/2018
3	CystathionineIBA 01/2019 - 07/2012
3	IronIBA 10/2017 - 01/2016
3	HepcidinsIBA 10/2017 - 01/2016
2	hirsutineIBA 01/2022 - 01/2011
2	Silicon Dioxide (Silica)FDA LinkGeneric 12/2021 - 01/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2020 - 04/2005
2	GasotransmittersIBA 01/2019 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 09/2006
2	Delayed-Action PreparationsIBA 04/2015 - 01/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012 - 07/2005
2	Superoxide DismutaseIBA 11/2010 - 08/2003
2	Malondialdehyde (Propanedial)IBA 11/2010 - 08/2009
2	Biological ProductsIBA 01/2010 - 05/2009
2	S-allylcysteine (allyl cysteine)IBA 08/2009 - 11/2007
2	Messenger RNA (mRNA)IBA 08/2008 - 08/2003
2	Ramipril (Altace)FDA LinkGeneric 04/2005 - 08/2003
1	Plant ExtractsIBA 06/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2022
1	Tryptophan (L-Tryptophan)FDA Link 06/2022
1	indoleIBA 06/2022
1	IndolesIBA 06/2022
1	Cofilin 1IBA 01/2022
1	Phosphotransferases (Kinase)IBA 12/2021
1	Histone MethyltransferasesIBA 12/2021
1	Oxygen (Dioxygen)IBA 12/2021
1	16S Ribosomal RNAIBA 08/2021
1	A 7 (A-7)IBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	Ketoprofen (Orudis)FDA LinkGeneric 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	CateninsIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 12/2020
1	ProcalcitoninIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	GSK-J4IBA 01/2019
1	ApolipoproteinsIBA 01/2019
1	CollagenIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Dextran SulfateIBA 01/2019
1	InflammasomesIBA 01/2019
1	Becaplermin (PDGF-BB)FDA Link 12/2018

Therapy/Procedure

3	Therapeutics 01/2017 - 09/2006
1	Oral Administration 01/2021